Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Director comp.
Credit agrmnt [a]
Acq. announced
Consulting agrmnt
Quarterly results
|
|
Horizon Therapeutics Public Ltd Co (HZNP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/06/2023 |
4
| Watkins Thomas (Director) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Disposed/sold 110,447 shares
@ $116.5, valued at
$12.9M
Disposed/sold 55,953 shares
@ $116.5, valued at
$6.5M
Disposed/sold 10,000 shares
@ $116.5, valued at
$1.2M
Disposed/sold 8,548 options to buy
@ $28.53, valued at
$243.9k
Disposed/sold 23,092 options to buy
@ $15.23, valued at
$351.7k
Disposed/sold 31,153 options to buy
@ $15.12, valued at
$471k
Disposed/sold 10,838 options to buy
@ $13.87, valued at
$150.3k
Disposed/sold 4,016 restricted stock units
@ $0 |
|
| 10/06/2023 |
4
| Mahony Susan (Director) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Disposed/sold 9,345 shares
@ $116.5, valued at
$1.1M
Disposed/sold 9,306 shares
@ $116.5, valued at
$1.1M
Disposed/sold 4,016 restricted stock units
@ $0 |
|
| 10/06/2023 |
4
| Witz Pascale (Director) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Disposed/sold 25,672 shares
@ $116.5, valued at
$3M
Disposed/sold 20,279 shares
@ $116.5, valued at
$2.4M
Disposed/sold 52,232 options to buy
@ $12.19, valued at
$636.7k
Disposed/sold 32,161 options to buy
@ $13.87, valued at
$446.1k
Disposed/sold 4,016 restricted stock units
@ $0 |
|
| 10/06/2023 |
4
| GREY MICHAEL G (Director) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Disposed/sold 39,361 shares
@ $116.5, valued at
$4.6M
Disposed/sold 48,031 shares
@ $116.5, valued at
$5.6M
Disposed/sold 10,000 shares
@ $116.5, valued at
$1.2M
Disposed/sold 8,548 options to buy
@ $28.53, valued at
$243.9k
Disposed/sold 23,092 options to buy
@ $15.23, valued at
$351.7k
Disposed/sold 31,153 options to buy
@ $15.12, valued at
$471k
Disposed/sold 32,161 options to buy
@ $13.87, valued at
$446.1k
Disposed/sold 4,016 restricted stock units
@ $0 |
|
| 10/06/2023 |
4
| Daniel William F (Director) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Disposed/sold 31,915 shares
@ $116.5, valued at
$3.7M
Disposed/sold 47,670 shares
@ $116.5, valued at
$5.6M
Disposed/sold 13,286 options to buy
@ $12.7, valued at
$168.7k
Disposed/sold 8,548 options to buy
@ $28.53, valued at
$243.9k
Disposed/sold 23,092 options to buy
@ $15.23, valued at
$351.7k
Disposed/sold 31,153 options to buy
@ $15.12, valued at
$471k
Disposed/sold 32,161 options to buy
@ $13.87, valued at
$446.1k
Disposed/sold 4,016 restricted stock units
@ $0 |
|
| 10/06/2023 |
4
| Himawan Jeff (Director) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Disposed/sold 44,546 shares
@ $116.5, valued at
$5.2M
Disposed/sold 36,609 shares
@ $116.5, valued at
$4.3M
Disposed/sold 7,873 shares
@ $116.5, valued at
$917.2k
Disposed/sold 23,092 options to buy
@ $15.23, valued at
$351.7k
Disposed/sold 31,153 options to buy
@ $15.12, valued at
$471k
Disposed/sold 4,016 restricted stock units
@ $0 |
|
| 10/06/2023 |
4
| Shannon James Samuel (Director) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Disposed/sold 33,156 shares
@ $116.5, valued at
$3.9M
Disposed/sold 23,638 shares
@ $116.5, valued at
$2.8M
Disposed/sold 8,150 options to buy
@ $12.19, valued at
$99.3k
Disposed/sold 32,161 options to buy
@ $13.87, valued at
$446.1k
Disposed/sold 4,016 restricted stock units
@ $0 |
|
| 10/06/2023 |
4
| SANTINI GINO (Director) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Disposed/sold 100,959 shares
@ $116.5, valued at
$11.8M
Disposed/sold 18,655 shares
@ $116.5, valued at
$2.2M
Disposed/sold 8,548 options to buy
@ $28.53, valued at
$243.9k
Disposed/sold 31,153 options to buy
@ $15.12, valued at
$471k
Disposed/sold 32,161 options to buy
@ $13.87, valued at
$446.1k
Disposed/sold 4,016 restricted stock units
@ $0 |
|
| 10/06/2023 |
4
| McIlvenny Patrick (Chief Accounting Officer) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Disposed/sold 6,874 shares
@ $116.5, valued at
$800.8k
Disposed/sold 2,198 restricted stock units
@ $0
Disposed/sold 3,809 restricted stock units
@ $0
Disposed/sold 11,498 restricted stock units
@ $0 |
|
| 10/06/2023 |
4
| Pasternak Andy (EVP, Chief Strategy Officer) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Disposed/sold 56,338 shares
@ $116.5, valued at
$6.6M
Disposed/sold 11,643 restricted stock units
@ $0
Disposed/sold 15,870 restricted stock units
@ $0
Disposed/sold 22,997 restricted stock units
@ $0
Disposed/sold 15,281 options to buy
@ $0
Disposed/sold 5,816 options to buy
@ $0
Disposed/sold 34,928 options to buy
@ $0
Disposed/sold 4,761 options to buy
@ $0
Disposed/sold 14,282 options to buy
@ $0
Disposed/sold 23,806 options to buy
@ $0
Disposed/sold 11,499 options to buy
@ $0 |
|
| 10/06/2023 |
4
| Thompson Elizabeth H.Z. (EVP, Research & Development) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Disposed/sold 14,575 shares
@ $116.5, valued at
$1.7M
Disposed/sold 4,657 restricted stock units
@ $0
Disposed/sold 14,283 restricted stock units
@ $0
Disposed/sold 20,697 restricted stock units
@ $0
Disposed/sold 4,285 options to buy
@ $0
Disposed/sold 12,854 options to buy
@ $0
Disposed/sold 21,426 options to buy
@ $0
Disposed/sold 10,349 options to buy
@ $0
Disposed/sold 5,174 options to buy
@ $0 |
|
| 10/06/2023 |
4
| Cox Aaron (EVP, CFO) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Disposed/sold 556 shares
@ $116.5, valued at
$64.8k
Disposed/sold 9,314 restricted stock units
@ $0
Disposed/sold 15,870 restricted stock units
@ $0
Disposed/sold 22,997 restricted stock units
@ $0
Disposed/sold 12,226 options to buy
@ $0
Disposed/sold 4,654 options to buy
@ $0
Disposed/sold 27,942 options to buy
@ $0
Disposed/sold 4,761 options to buy
@ $0
Disposed/sold 14,282 options to buy
@ $0
Disposed/sold 23,806 options to buy
@ $0
Disposed/sold 11,499 options to buy
@ $0 |
|
| 10/06/2023 |
4
| Walbert Timothy P (Chairman, President and CEO) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Disposed/sold 616,772 shares
@ $116.5, valued at
$71.9M
Disposed/sold 107,739 shares
@ $116.5, valued at
$12.6M
Disposed/sold 100,300 shares
@ $116.5, valued at
$11.7M
Disposed/sold 49,935 shares
@ $116.5, valued at
$5.8M
Disposed/sold 742,565 options to buy
@ $22.14, valued at
$16.4M
Disposed/sold 1,650,000 options to buy
@ $28.53, valued at
$47.1M
Disposed/sold 34,929 restricted stock units
@ $0
Disposed/sold 49,198 restricted stock units
@ $0
Disposed/sold 71,290 restricted stock units
@ $0
Disposed/sold 45,843 options to buy
@ $0
Disposed/sold 17,448 options to buy
@ $0 |
|
| 10/06/2023 |
4
| DesJardin Michael A. (EVP, Technical Operations) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Disposed/sold 126,838 shares
@ $116.5, valued at
$14.8M
Disposed/sold 10,479 restricted stock units
@ $0
Disposed/sold 14,283 restricted stock units
@ $0
Disposed/sold 20,697 restricted stock units
@ $0
Disposed/sold 13,753 options to buy
@ $0
Disposed/sold 5,236 options to buy
@ $0
Disposed/sold 31,436 options to buy
@ $0
Disposed/sold 4,285 options to buy
@ $0
Disposed/sold 12,854 options to buy
@ $0
Disposed/sold 21,426 options to buy
@ $0
Disposed/sold 10,349 options to buy
@ $0 |
|
| 10/06/2023 |
4
| Clayton Sean M. (EVP, General Counsel) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Disposed/sold 7,655 shares
@ $116.5, valued at
$891.8k
Disposed/sold 745 shares
@ $116.5, valued at
$86.8k
Disposed/sold 28,258 restricted stock units
@ $0
Disposed/sold 22,997 restricted stock units
@ $0
Disposed/sold 5,749 options to buy
@ $0
Disposed/sold 11,499 options to buy
@ $0 |
|
| 10/06/2023 |
4
| SHERMAN JEFFREY W (EVP and Chief Medical Officer) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Disposed/sold 2,655 shares
@ $116.5, valued at
$309.3k
Disposed/sold 105,808 shares
@ $116.5, valued at
$12.3M
Disposed/sold 80,944 shares
@ $116.5, valued at
$9.4M
Disposed/sold 45,352 shares
@ $116.5, valued at
$5.3M
Disposed/sold 164,469 options to buy
@ $22.14, valued at
$3.6M
Disposed/sold 9,314 restricted stock units
@ $0
Disposed/sold 12,696 restricted stock units
@ $0
Disposed/sold 18,397 restricted stock units
@ $0
Disposed/sold 12,226 options to buy
@ $0
Disposed/sold 4,654 options to buy
@ $0
Disposed/sold 27,942 options to buy
@ $0 |
|
| 10/06/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/06/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/06/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/06/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/06/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/06/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/06/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/06/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/06/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/06/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/06/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/06/2023 |
8-K
| Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa... |
| 10/06/2023 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 10/05/2023 |
8-K
| Other Events Interactive Data |
| 10/02/2023 |
4
| SANTINI GINO (Director) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Exercised 23,092 options to buy
@ $15.23, valued at
$351.7k
|
|
| 10/02/2023 |
4
| Watkins Thomas (Director) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Exercised 40,000 options to buy
@ $12.29, valued at
$491.6k
Exercised 20,000 options to buy
@ $15.96, valued at
$319.2k
Exercised 21,323 options to buy
@ $13.87, valued at
$295.8k
|
|
| 10/02/2023 |
4
| Shannon James Samuel (Director) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Exercised 11,850 options to buy
@ $12.19, valued at
$144.5k
|
|
| 09/28/2023 |
4
| GREY MICHAEL G (Director) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Exercised 20,000 options to buy
@ $15.96, valued at
$319.2k
|
|
|
|
|